Skip to main content

Brighthouse Financial Announces Fourth Quarter and Full Year 2025 Results

  • Preliminary combined risk-based capital ("RBC") ratio of 456%; holding company liquid assets of $0.9 billion
  • Annuity sales for full year 2025 of $10.3 billion, primarily driven by record sales of Shield Level Annuities
  • Record life sales for full year 2025 of $143 million, primarily driven by sales of Brighthouse SmartCare
  • Fourth quarter 2025 net income available to shareholders of $112 million, or $1.93 per diluted share
  • Fourth quarter 2025 adjusted earnings, less notable items*, of $227 million, or $3.93 per diluted share

Brighthouse Financial, Inc. ("Brighthouse Financial" or the "company") (Nasdaq: BHF) announced today its financial results for the fourth quarter and full year ended December 31, 2025.

Fourth Quarter and Full Year 2025 Results

The company reported net income available to shareholders of $112 million in the fourth quarter of 2025, or $1.93 per diluted share, compared with net income available to shareholders of $646 million in the fourth quarter of 2024, or $10.79 per diluted share. The company anticipates volatility in net income (loss) given the differences between its hedge target and GAAP reserves, which are impacted by market performance.

The company ended the fourth quarter of 2025 with common stockholders' equity ("book value") of $5.1 billion, or $88.66 per common share, and book value, excluding accumulated other comprehensive income ("AOCI") of $8.8 billion, or $153.89 per common share.

For the fourth quarter of 2025, the company reported adjusted earnings* of $214 million, or $3.70 per diluted share, compared with adjusted earnings of $304 million, or $5.07 per diluted share, for the fourth quarter of 2024.

_________

* Information regarding the non-GAAP and other financial measures included in this news release and a reconciliation of such non-GAAP financial measures to the most directly comparable GAAP measures are provided in the Non-GAAP and Other Financial Disclosures discussion below, as well as in the tables that accompany this news release and/or the Fourth Quarter 2025 Brighthouse Financial, Inc. Financial Supplement (which is available on the Brighthouse Financial Investor Relations webpage at http://investor.brighthousefinancial.com). Additional information regarding notable items can be found on the last page of this news release.

Adjusted earnings for the quarter reflect a $13 million unfavorable notable item, or $0.22 per diluted share, related to actuarial refinements.

On a full year basis, the company reported net income available to shareholders of $331 million in 2025, or $5.71 per diluted share, compared with net income available to shareholders of $286 million in 2024, or $4.64 per diluted share. The company anticipates volatility in net income (loss) given the differences between its hedge target and GAAP reserves, which are impacted by market performance. Full year 2025 adjusted earnings, less notable items*, were $931 million, or $16.07 per diluted share, compared with full year 2024 adjusted earnings, less notable items, of $1,209 million, or $19.63 per diluted share.

Corporate expenses in the fourth quarter of 2025 were $234 million on a pre-tax basis. This represents an increase from $210 million of corporate expenses in the fourth quarter of 2024 and $205 million in the third quarter of 2025. For the full year 2025, corporate expenses totaled $880 million, compared with $820 million for the full year 2024. The corporate expenses include costs incurred in connection with the previously announced pending acquisition of the company of $15 million and $32 million for the fourth quarter and full year 2025, respectively.

The company's full year 2025 annuity sales were $10.3 billion, an increase of 3% year-over-year. Annuity sales were flat sequentially and increased 22% quarter-over-quarter, driven by record sales of Shield Level Annuities, which increased 4% year-over-year, 10% quarter-over-quarter, and 1% sequentially. Life sales in 2025 were a record $143 million, an increase of 19% year-over-year, 9% quarter-over-quarter and a decrease of 5% sequentially.

Key Metrics (Unaudited, dollars in millions except share and per share amounts)

 

 

 

As of or For the Three Months Ended

 

 

December 31, 2025

 

December 31, 2024

 

 

Total

 

Per share

 

Total

 

Per share

Net income (loss) available to shareholders (1)

 

$112

 

$1.93

 

$646

 

$10.79

Adjusted earnings (1)

 

$214

 

$3.70

 

$304

 

$5.07

Adjusted earnings, less notable items (1)

 

$227

 

$3.93

 

$352

 

$5.88

Weighted average common shares outstanding - diluted (1)

 

57,829,186

 

N/A

 

59,823,854

 

N/A

 

 

 

 

 

 

 

 

 

Book value

 

$5,069

 

$88.66

 

$3,260

 

$55.60

Book value, excluding AOCI

 

$8,798

 

$153.89

 

$8,538

 

$145.63

Ending common shares outstanding

 

57,171,217

 

N/A

 

58,629,049

 

N/A

 

 

 

 

 

 

 

 

 

(1) Per share amounts are on a diluted basis and may not recalculate due to rounding. See Non-GAAP and Other Financial Disclosures discussion in this news release.

Results by Segment (Unaudited, in millions)

 

 

 

For the Three Months Ended

ADJUSTED EARNINGS (LOSS) (1)

 

December 31,
2025

 

September 30,
2025

 

December 31,
2024

Annuities

 

$304

 

$304

 

$279

Life

 

$18

 

$40

 

$52

Run-off

 

$(58)

 

$641

 

$(27)

Corporate & Other

 

$(50)

 

$(15)

 

$—

(1) The company uses the term "adjusted loss" throughout this news release to refer to negative adjusted earnings values.

Sales (Unaudited, in millions)

 

 

 

For the Three Months Ended

 

 

December 31,
2025

 

September 30,
2025

 

December 31,
2024

Annuities (1)

 

$2,734

 

$2,731

 

$2,239

Life

 

$36

 

$38

 

$33

 

 

 

 

 

 

 

(1) Annuities sales include sales of a fixed index annuity product, which represents 100% of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. Sales of this product were $142 million for the fourth quarter of 2025, $126 million for the third quarter of 2025 and $62 million for the fourth quarter of 2024.

Annuities

Adjusted earnings in the Annuities segment were $304 million in the current quarter, compared with adjusted earnings of $279 million in the fourth quarter of 2024 and adjusted earnings of $304 million in the third quarter of 2025.

There were no notable items in the current quarter. The fourth quarter of 2024 included a $48 million unfavorable notable item related to actuarial model updates, and the third quarter of 2025 included a $7 million unfavorable notable item related to the annual actuarial review and related refinements.

On a quarter-over-quarter basis, adjusted earnings, less notable items, reflect lower fees and higher amortization of deferred acquisition costs ("DAC"). On a sequential basis, adjusted earnings, less notable items, reflect lower fees and higher amortization of DAC, partially offset by higher net investment income.

As mentioned above, the company's full year 2025 annuity sales were $10.3 billion, an increase of 3% year-over-year. Annuity sales were flat sequentially and increased 22% quarter-over-quarter, driven by record sales of Shield Level Annuities, which increased 4% year-over-year, 10% quarter-over-quarter, and 1% sequentially.

Life

The Life segment had adjusted earnings of $18 million in the current quarter, compared with adjusted earnings of $52 million in the fourth quarter of 2024 and adjusted earnings of $40 million in the third quarter of 2025.

The current quarter included a $6 million unfavorable notable item. There were no notable items in the fourth quarter of 2024. The third quarter of 2025 included $11 million of favorable notable items related to the annual actuarial review and related refinements.

On a quarter-over-quarter basis, adjusted earnings, less notable items, reflect a lower underwriting margin, lower net investment income and higher expenses. On a sequential basis, adjusted earnings, less notable items, reflect lower net investment income.

As mentioned above, the company reported record life sales of $143 million in 2025. Life sales increased 19% year-over-year, 9% quarter-over-quarter and decreased 5% sequentially.

Run-off

The Run-off segment had an adjusted loss of $58 million in the current quarter, compared with an adjusted loss of $27 million in the fourth quarter of 2024 and adjusted earnings of $641 million in the third quarter of 2025.

The current quarter included a $7 million unfavorable notable item. There were no notable items in the fourth quarter of 2024. The third quarter of 2025 included $705 million of favorable notable items related to the annual actuarial review and related refinements.

On a quarter-over-quarter basis, the adjusted loss, less notable items, reflects lower net investment income and a lower underwriting margin, partially offset by lower expenses. On a sequential basis, the adjusted loss, less notable items, reflects higher net investment income.

Corporate & Other

The Corporate & Other segment had an adjusted loss of $50 million in the current quarter, compared with break-even adjusted earnings in the fourth quarter of 2024 and an adjusted loss of $15 million in the third quarter of 2025.

There were no notable items in the current quarter or the comparison quarters.

On a quarter-over-quarter basis, the adjusted loss reflects higher expenses related to the previously mentioned costs incurred in connection with the pending acquisition of the company and lower net investment income. On a sequential basis, the adjusted loss reflects higher expenses related to the previously mentioned costs incurred in connection with the pending acquisition of the company.

Net Investment Income and Adjusted Net Investment Income (Unaudited, in millions)

 

 

 

For the Three Months Ended

 

 

December 31,
2025

 

September 30,
2025

 

December 31,
2024

Net investment income

 

$1,328

 

$1,334

 

$1,373

Adjusted net investment income

 

$1,334

 

$1,327

 

$1,376

Net Investment Income

Net investment income was $1,328 million and adjusted net investment income* was $1,334 million in the current quarter.

Adjusted net investment income decreased $42 million on a quarter-over-quarter basis primarily driven by a reduction in the size of the institutional spread margin business and the impact of lower short-term interest rates. Adjusted net investment income increased $7 million sequentially, driven by higher alternative investment income.

The adjusted net investment income yield* was 4.44% during the quarter.

Statutory Capital and Liquidity (Unaudited, in billions)

 

 

 

As of

 

 

December 31,
2025 (1)

 

September 30,
2025

 

December 31,
2024

Statutory combined total adjusted capital

 

$5.3

 

$5.4

 

$5.4

 

 

 

 

 

 

 

(1) Reflects preliminary statutory results as of December 31, 2025.

Capitalization

As of December 31, 2025:

  • Statutory combined total adjusted capital(1) was $5.3 billion
  • Combined RBC ratio(1) of 456%, which is above our target range of 400% to 450% in normal market conditions
  • The combined RBC ratio reflects:
    • a reserve increase from the statutory annual actuarial review completed in the fourth quarter,
    • a reduction in required capital from this actuarial review, and
    • a benefit from a reinsurance transaction with a third party to reinsure certain universal life policies with secondary guarantees and certain term life policies, which was entered into in the fourth quarter.
  • Holding company liquid assets were $0.9 billion, which reflects the previously mentioned costs incurred in connection with the pending acquisition of the company and the timing of senior debt interest expense.

_______________

(1) Reflects preliminary statutory results as of December 31, 2025.

Pending Merger with Aquarian Capital

On November 6, 2025, Aquarian Capital LLC (“Aquarian Capital”), a diversified global holding company with a strategic portfolio of insurance and asset management businesses, and Brighthouse Financial, announced that they had entered into a definitive merger agreement under which an affiliate of Aquarian Capital will acquire Brighthouse Financial for $70.00 per share in an all-cash transaction valued at approximately $4.1 billion.

At a special meeting held on February, 12, 2026, Brighthouse Financial stockholders voted to adopt the merger agreement. The transaction is expected to close in 2026 and is subject to customary closing conditions, including receipt of insurance regulatory approvals.

About Brighthouse Financial, Inc.

Brighthouse Financial, Inc. (Brighthouse Financial) (Nasdaq: BHF) is on a mission to help people achieve financial security. As one of the largest providers of annuities and life insurance in the U.S.,(1) we specialize in products designed to help people protect what they've earned and ensure it lasts. Learn more at brighthousefinancial.com.

(1) Ranked by 2024 admitted assets. Best's Review®: Top 200 U.S. Life/Health Insurers. AM Best, 2025.

Note Regarding Forward-Looking Statements

This press release, and any related oral statements, contain various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections. Words such as “estimate,” “expect,” “project,” “may,” “will,” “could,” “intend,” “goal,” “target,” “guidance,” “forecast,” “preliminary,” “objective,” “continue,” “aim,” “plan,” “believe” and similar expressions or the negative of those expressions or verbs, identify forward-looking statements. Readers are cautioned that these statements are not guarantees of future performance. Forward-looking statements are not historical facts but instead represent only Brighthouse Financial’s beliefs regarding future events, which may by their nature be inherently uncertain, and some of which may be outside Brighthouse Financial’s control.

Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors include, among others, Brighthouse Financial’s ability to complete the merger on the timeframe or in the manner currently anticipated or at all, including due to a failure to obtain the regulatory approvals required for the closing of the merger or the occurrence of any event, change or other circumstance that could give rise to the right of one or both of the parties to terminate the merger agreement; the effect of the pendency of the merger on Brighthouse Financial’s ongoing business and operations, including disruption to Brighthouse Financial’s business relationships, the diversion of management’s attention from ongoing business operations and opportunities, or the outcome of any legal proceedings that may be instituted against Aquarian Capital or Brighthouse Financial following announcement of the merger; restrictions on the conduct of Brighthouse Financial’s business prior to the closing of the merger and on Brighthouse Financial’s ability to pursue alternatives to the merger; the possibility that the merger may be more expensive to complete than anticipated, including as a result of unexpected factors or events; differences between actual experience and actuarial assumptions and the effectiveness of Brighthouse Financial's actuarial models; higher risk management costs and exposure to increased market risk due to guarantees within certain of Brighthouse Financial's products; the effectiveness of Brighthouse Financial's risk management strategy and the impacts of such strategy on volatility in Brighthouse Financial's profitability measures and the negative effects on Brighthouse Financial's statutory capital; material differences between actual outcomes and the sensitivities calculated under certain scenarios that Brighthouse Financial may utilize in connection with its risk management strategies; the impact of interest rates on Brighthouse Financial's future ULSG policyholder obligations and net income volatility; the potential material adverse effect of changes in accounting standards, practices or policies applicable to Brighthouse Financial, including changes in the accounting for long-duration contracts; loss of business and other negative impacts resulting from a downgrade or a potential downgrade in Brighthouse Financial's financial strength or credit ratings; the availability of reinsurance and the ability of the counterparties to Brighthouse Financial's reinsurance or indemnification arrangements to perform their obligations thereunder; heightened competition, including with respect to service, product features, product mix, scale, price, actual or perceived financial strength, claims-paying ratings, credit ratings, e-business capabilities and name recognition; Brighthouse Financial's ability to market and distribute its products through distribution channels and maintain relationships with key distribution partners; any failure of third parties to provide services Brighthouse Financial needs, any failure of the practices and procedures of such third parties and any inability to obtain information or assistance it needs from third parties; the ability of Brighthouse Financial's subsidiaries to pay dividends to it, and its ability to pay dividends to its shareholders and repurchase its common stock; the risks associated with climate change; the adverse impact of public health crises, extreme mortality events or similar occurrences on Brighthouse Financial's business and the economy in general; the impact of adverse capital and credit market conditions, including with respect to Brighthouse Financial's ability to meet liquidity needs and access capital; the impact of economic conditions in the capital markets and the U.S. and global economy, as well as geopolitical events, tariffs imposed or threatened by the U.S. or foreign governments, military actions or catastrophic events, on Brighthouse Financial's profitability measures as well as its investment portfolio, including on realized and unrealized losses and impairments, net investment spread and net investment income; the financial risks that Brighthouse Financial's investment portfolio is subject to, including credit risk, interest rate risk, inflation risk, market valuation risk, liquidity risk, real estate risk, derivatives risk, and other factors outside Brighthouse Financial's control; the impact of changes in regulation and in supervisory and enforcement policies or interpretations thereof on Brighthouse Financial's insurance business or other operations; the potential material negative tax impact of potential future tax legislation that could make some of Brighthouse Financial's products less attractive to consumers or increase our tax liability; the effectiveness of Brighthouse Financial's policies, procedures and processes in managing risk; the loss or disclosure of confidential information, damage to Brighthouse Financial's reputation and impairment of its ability to conduct business effectively as a result of any failure in cyber- or other information security systems; whether all or any portion of the tax consequences of Brighthouse Financial's separation from MetLife, Inc. are not as expected, leading to material additional taxes or material adverse consequences to tax attributes that impact Brighthouse Financial; other factors that may affect future results of Brighthouse Financial; and management’s response to any of the aforementioned factors.

Furthermore, such forward-looking statements speak only as of the date of this press release. Except as required by law, the parties undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements. Risks or uncertainties (i) that are not currently known to the parties, (ii) that the parties currently deem to be immaterial or (iii) that could apply to any company could also materially adversely affect the future results of Brighthouse Financial. Additional information concerning certain factors is contained in Brighthouse Financial’s SEC filings, including but not limited to its most recent Annual Report on Form 10-K, as well as subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

The information contained on or connected to any websites referenced in this press release is not incorporated by reference into this press release.

Non-GAAP and Other Financial Disclosures

Our definitions of non-GAAP and other financial measures may differ from those used by other companies.

Non-GAAP Financial Disclosures

We present certain measures of our performance that are not calculated in accordance with accounting principles generally accepted in the United States of America, also known as "GAAP." We believe that these non-GAAP financial measures enhance the understanding of our performance by the investor community by highlighting the results of operations and the underlying profitability drivers of our business.

The following non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:

 

 

Non-GAAP financial measures:

Most directly comparable GAAP financial measures:

adjusted earnings

net income (loss) available to shareholders (1)

adjusted earnings, less notable items

net income (loss) available to shareholders (1)

adjusted revenues

revenues

adjusted expenses

expenses

adjusted earnings per common share

earnings per common share, diluted (1)

adjusted earnings per common share, less notable items

earnings per common share, diluted (1)

adjusted return on common equity

return on common equity (2)

adjusted return on common equity, less notable items

return on common equity (2)

adjusted net investment income

net investment income

adjusted net investment income yield

net investment income yield

__________________

 

 

(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.'s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share.

(2) Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.'s common stockholders' equity.

Reconciliations to the most directly comparable historical GAAP measures are included for those measures which are presented herein. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are not accessible on a forward-looking basis because we believe it is not possible without unreasonable efforts to provide other than a range of net investment gains and losses and net derivative gains and losses, which can fluctuate significantly within or outside the range and from period to period and may have a material impact on net income (loss) available to shareholders.

Adjusted Earnings, Adjusted Revenues and Adjusted Expenses

Adjusted earnings is a financial measure used by management to evaluate performance and facilitate comparisons to industry results. This financial measure, which may be positive or negative, focuses on our primary businesses by excluding the impact of market volatility, which could distort trends. Adjusted earnings was updated during the first quarter of 2025 in connection with the establishment of a trading portfolio comprised of certain fixed income securities. The company did not have trading securities prior to the first quarter of 2025.

Adjusted earnings reflect adjusted revenues less (i) adjusted expenses, (ii) provision for income tax expense (benefit), (iii) net income (loss) attributable to noncontrolling interests and (iv) preferred stock dividends. Provided below are the adjustments to GAAP revenues and GAAP expenses used to calculate adjusted revenues and adjusted expenses, respectively.

The following items are excluded from total revenues in calculating the adjusted revenues component of adjusted earnings:

  • Net investment gains (losses);
  • Investment gains (losses) on trading securities measured at estimated fair value through net investment income; and
  • Net derivative gains (losses) ("NDGL"), excluding earned income and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment ("Investment Hedge Adjustments").

The following items are excluded from total expenses in calculating the adjusted expenses component of adjusted earnings:

  • Change in market risk benefits; and
  • Change in fair value of the crediting rate on experience-rated contracts and market value adjustments on institutional group annuities that are economically offset by gains (losses) on the related trading securities ("Market Value Adjustments").

The provision for income tax related to adjusted earnings is calculated using the statutory tax rate of 21%, net of impacts related to the dividends received deduction, tax credits and current period non-recurring items.

Consistent with GAAP guidance for segment reporting, adjusted earnings is also our GAAP measure of segment performance.

Adjusted Earnings per Common Share and Adjusted Return on Common Equity

Adjusted earnings per common share and adjusted return on common equity are measures used by management to evaluate the execution of our business strategy and align such strategy with our shareholders' interests.

Adjusted earnings per common share is defined as adjusted earnings for the period divided by the weighted average number of fully diluted shares of common stock outstanding for the period. The weighted average common shares outstanding used to calculate adjusted earnings per share will differ from such shares used to calculate diluted net income (loss) available to shareholders per common share when the inclusion of dilutive shares has an anti-dilutive effect for one calculation but not for the other.

Adjusted return on common equity is defined as total annual adjusted earnings on a four quarter trailing basis, divided by the simple average of the most recent five quarters of total Brighthouse Financial, Inc.'s common stockholders' equity, excluding AOCI.

Adjusted Net Investment Income

Adjusted net investment income is used by management to measure our performance, and we believe it enhances the understanding of our investment portfolio results. Adjusted net investment income represents GAAP net investment income plus Investment Hedge Adjustments less investment gains (losses) on trading securities.

Adjusted Net Investment Income Yield

Similar to adjusted net investment income, adjusted net investment income yield is used by management as a performance measure that we believe enhances the understanding of our investment portfolio results. Adjusted net investment income yield represents adjusted net investment income as a percentage of average quarterly asset carrying values. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. Investment fee and expense yields are calculated as a percentage of average quarterly asset estimated fair values. Asset estimated fair values exclude collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties.

Other Financial Disclosures

Corporate Expenses

Corporate expenses includes functional department expenses, public company expenses, certain investment expenses, retirement funding and incentive compensation.

Notable Items

Certain of the non-GAAP measures described above may be presented further adjusted to exclude notable items. Notable items reflect the unfavorable (favorable) after-tax impact on our results of certain unanticipated items and events, as well as certain items and events that were anticipated. The presentation of notable items and non-GAAP measures, less notable items is intended to help investors better understand our results and to evaluate and forecast those results.

Book Value per Common Share and Book Value per Common Share, excluding AOCI

Brighthouse uses the term "book value" to refer to "Brighthouse Financial, Inc.'s common stockholders' equity, including AOCI." Book value per common share is defined as ending Brighthouse Financial, Inc.'s common stockholders' equity, including AOCI, divided by ending common shares outstanding. Book value per common share, excluding AOCI, is defined as ending Brighthouse Financial, Inc.'s common stockholders' equity, excluding AOCI, divided by ending common shares outstanding.

CTE70

CTE70 is defined as the amount of assets required to satisfy contract holder obligations across market environments in the average of the worst thirty percent of a set of capital market scenarios over the life of the contracts.

CTE98

CTE98 is defined as the amount of assets required to satisfy contract holder obligations across market environments in the average of the worst two percent of a set of capital market scenarios over the life of the contracts.

Holding Company

Holding company means, collectively, Brighthouse Financial, Inc., Brighthouse Holdings, LLC, and Brighthouse Services, LLC.

Holding Company Liquid Assets

Holding company liquid assets include liquid assets in Brighthouse Financial, Inc., Brighthouse Holdings, LLC, and Brighthouse Services, LLC. Liquid assets are comprised of cash and cash equivalents, short-term investments and publicly-traded securities, excluding assets that are pledged or otherwise committed. Assets pledged or otherwise committed include assets held in trust.

Total Adjusted Capital

Total adjusted capital primarily consists of statutory capital and surplus, as well as the statutory asset valuation reserve. When referred to as “combined,” represents that of our insurance subsidiaries as a whole.

Sales

Life insurance sales consist of 100 percent of annualized new premium for term life, first-year paid premium for whole life, universal life, and variable universal life, and total paid premium for indexed universal life. We exclude company-sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life.

Annuity sales consist of 100 percent of direct statutory premiums, except for fixed index annuity sales, which represents 100 percent of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. Annuity sales exclude certain internal exchanges. These sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.

Normalized Statutory Earnings (Loss)

Normalized statutory earnings (loss) is used by management to measure our insurance companies’ ability to pay future distributions and incorporates the effectiveness of our hedging program as well as other factors related to our business. Normalized statutory earnings (loss) is calculated as statutory pre-tax net gain (loss) from operations adjusted for the favorable or unfavorable impacts of (i) net realized capital gains (losses) before capital gains tax (excluding gains (losses) and taxes transferred to the interest maintenance reserve), (ii) the change in total asset requirement at CTE98, net of the change in our variable annuity reserves, which are calculated at CTE70, and (iii) pre-tax unrealized gains (losses) associated with our variable annuities and Shield hedges, net of reinsurance, and other equity risk management strategies. Normalized statutory earnings (loss) may be further adjusted for certain unanticipated items that impact our results in order to help management and investors better understand, evaluate and forecast those results.

Risk-Based Capital Ratio

The risk-based capital ratio is a method of measuring an insurance company’s capital, taking into consideration its relative size and risk profile, in order to ensure compliance with minimum regulatory capital requirements set by the National Association of Insurance Commissioners. When referred to as “combined,” represents that of our insurance subsidiaries as a whole. The reporting of our combined risk-based capital ratio is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities.

Condensed Statements of Operations (Unaudited, in millions)

 

 

 

For the Three Months Ended

Revenues

 

December 31,
2025

 

September 30,
2025

 

December 31,
2024

Premiums

 

$173

 

$170

 

$207

Universal life and investment-type product policy fees

 

534

 

531

 

540

Net investment income

 

1,328

 

1,334

 

1,373

Other revenues

 

133

 

143

 

150

Revenues before NIGL and NDGL

 

2,168

 

2,178

 

2,270

Net investment gains (losses)

 

(23)

 

48

 

(73)

Net derivative gains (losses)

 

(456)

 

(410)

 

(992)

Total revenues

 

$1,689

 

$1,816

 

$1,205

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

Policyholder benefits and claims

 

$697

 

$(252)

 

$662

Interest credited to policyholder account balances

 

529

 

561

 

569

Amortization of DAC and VOBA

 

159

 

153

 

148

Change in market risk benefits

 

(349)

 

289

 

(1,487)

Interest expense on debt

 

38

 

38

 

38

Other expenses

 

465

 

442

 

441

Total expenses

 

1,539

 

1,231

 

371

Income (loss) before provision for income tax

 

150

 

585

 

834

Provision for income tax expense (benefit)

 

12

 

104

 

162

Net income (loss)

 

138

 

481

 

672

Less: Net income (loss) attributable to noncontrolling interests

 

1

 

2

 

1

Net income (loss) attributable to Brighthouse Financial, Inc.

 

137

 

479

 

671

Less: Preferred stock dividends

 

25

 

26

 

25

Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders

 

$112

 

$453

 

$646

Condensed Balance Sheets (Unaudited, in millions)

 

 

 

As of

ASSETS

 

December 31,
2025

 

September 30,
2025

 

December 31,
2024

Investments:

 

 

 

 

 

 

Fixed maturity securities available-for-sale

 

$82,014

 

$81,537

 

$80,055

Trading securities

 

506

 

528

 

Equity securities

 

79

 

78

 

77

Mortgage loans

 

22,755

 

22,862

 

23,286

Policy loans

 

1,450

 

1,439

 

2,024

Limited partnerships and limited liability companies

 

4,696

 

4,816

 

4,827

Short-term investments

 

1,197

 

778

 

1,868

Other invested assets

 

7,932

 

8,842

 

5,250

Total investments

 

120,629

 

120,880

 

117,387

Cash and cash equivalents

 

5,387

 

6,606

 

5,045

Accrued investment income

 

1,260

 

1,350

 

1,277

Reinsurance recoverables

 

20,903

 

20,400

 

20,515

Premiums and other receivables

 

676

 

844

 

611

DAC and VOBA

 

4,567

 

4,603

 

4,710

Current income tax recoverable

 

16

 

17

 

19

Deferred income tax asset

 

1,442

 

1,531

 

1,875

Market risk benefit assets

 

1,060

 

979

 

1,092

Other assets

 

332

 

342

 

370

Separate account assets

 

85,528

 

87,127

 

85,636

Total assets

 

$241,800

 

$244,679

 

$238,537

LIABILITIES AND EQUITY

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Future policy benefits

 

$32,025

 

$32,021

 

$31,475

Policyholder account balances

 

87,952

 

88,703

 

87,989

Market risk benefit liabilities

 

8,063

 

8,529

 

8,329

Other policy-related balances

 

3,893

 

3,918

 

3,878

Payables for collateral under securities loaned and other transactions

 

4,705

 

4,347

 

3,891

Long-term debt

 

3,155

 

3,155

 

3,155

Other liabilities

 

9,646

 

10,451

 

9,160

Separate account liabilities

 

85,528

 

87,127

 

85,636

Total liabilities

 

234,967

 

238,251

 

233,513

Equity

 

 

 

 

 

 

Preferred stock, at par value

 

 

 

Common stock, at par value

 

1

 

1

 

1

Additional paid-in capital

 

13,870

 

13,893

 

13,927

Retained earnings (deficit)

 

(686)

 

(823)

 

(1,119)

Treasury stock

 

(2,688)

 

(2,688)

 

(2,572)

Accumulated other comprehensive income (loss)

 

(3,729)

 

(4,020)

 

(5,278)

Total Brighthouse Financial, Inc.’s stockholders’ equity

 

6,768

 

6,363

 

4,959

Noncontrolling interests

 

65

 

65

 

65

Total equity

 

6,833

 

6,428

 

5,024

Total liabilities and equity

 

$241,800

 

$244,679

 

$238,537

Reconciliation of Net Income (Loss) Available to Shareholders to Adjusted Earnings (Loss) and Adjusted Earnings, Less Notable Items, and Reconciliation of Net Income (Loss) Available to Shareholders per Common Share to Adjusted Earnings (Loss) per Common Share and Adjusted Earnings, Less Notable Items, per Common Share (Unaudited, in millions except per share data)

 

 

 

For the Three Months Ended

 

 

For the Year Ended

ADJUSTED EARNINGS, LESS NOTABLE ITEMS

 

December 31,
2025

 

September 30,
2025

 

December 31,
2024

 

 

December 31,
2025

 

December 31,
2024

Net income (loss) available to shareholders

 

$112

 

$453

 

$646

 

 

$331

 

$286

Less: Net investment gains (losses)

 

(23)

 

48

 

(73)

 

 

(97)

 

(295)

Less: Investment gains (losses) on trading securities

 

(7)

 

7

 

 

 

 

Less: Net derivative gains (losses), excluding investment hedge adjustments

 

(455)

 

(410)

 

(995)

 

 

(1,792)

 

(3,699)

Less: Change in market risk benefits

 

349

 

(289)

 

1,487

 

 

268

 

2,673

Less: Market value adjustments

 

6

 

(10)

 

14

 

 

(8)

 

13

Less: Provision for income tax (expense) benefit on reconciling adjustments

 

28

 

137

 

(91)

 

 

343

 

275

Adjusted earnings (loss)

 

214

 

970

 

304

 

 

1,617

 

1,319

Less: Notable items

 

(13)

 

709

 

(48)

 

 

686

 

110

Adjusted earnings, less notable items

 

$227

 

$261

 

$352

 

 

$931

 

$1,209

 

 

 

 

 

 

 

 

 

 

 

 

ADJUSTED EARNINGS, LESS NOTABLE ITEMS, PER COMMON SHARE (1)

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) available to shareholders per common share

 

$1.93

 

$7.89

 

$10.79

 

 

$5.71

 

$4.64

Less: Net investment gains (losses)

 

(0.40)

 

0.83

 

(1.22)

 

 

(1.67)

 

(4.79)

Less: Investment gains (losses) on trading securities

 

(0.12)

 

0.12

 

 

 

 

Less: Net derivative gains (losses), excluding investment hedge adjustments

 

(7.87)

 

(7.13)

 

(16.63)

 

 

(30.93)

 

(60.05)

Less: Change in market risk benefits

 

6.04

 

(5.02)

 

24.86

 

 

4.63

 

43.39

Less: Market value adjustments

 

0.10

 

(0.17)

 

0.23

 

 

(0.14)

 

0.21

Less: Provision for income tax (expense) benefit on reconciling adjustments

 

0.48

 

2.38

 

(1.52)

 

 

5.92

 

4.46

Less: Impact of inclusion of dilutive shares

 

 

 

 

 

 

Adjusted earnings (loss) per common share

 

3.70

 

16.87

 

5.07

 

 

27.92

 

21.40

Less: Notable items

 

(0.22)

 

12.33

 

(0.80)

 

 

11.84

 

1.79

Adjusted earnings, less notable items per common share

 

$3.93

 

$4.54

 

$5.88

 

 

$16.07

 

$19.63

 

 

 

 

 

 

 

 

 

 

 

 

(1) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. See Non-GAAP and Other Financial Disclosures discussion in this news release.

Reconciliation of Net Investment Income to Adjusted Net Investment Income (Unaudited, in millions)

 

 

 

For the Three Months Ended

ADJUSTED NET INVESTMENT INCOME (1)

 

December 31,
2025

 

September 30,
2025

 

December 31,
2024

Net investment income

 

$1,328

 

$1,334

 

$1,373

Add: Investment hedge adjustments

 

(1)

 

 

3

Less: Investment gains (losses) on trading securities

 

(7)

 

7

 

Adjusted net investment income

 

$1,334

 

$1,327

 

$1,376

Reconciliation of Investment Income Yield to Adjusted Net Investment Income Yield

 

 

 

For the Three Months Ended

ADJUSTED NET INVESTMENT INCOME YIELD (1)

 

December 31,
2025

 

September 30,
2025

 

December 31,
2024

Investment income yield

 

4.60%

 

4.54%

 

4.64%

Investment fees and expenses

 

(0.16)%

 

(0.14)%

 

(0.13)%

Adjusted net investment income yield

 

4.44%

 

4.40%

 

4.51%

Notable Items (Unaudited, in millions)

 

 

 

For the Three Months Ended

NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS

 

December 31,
2025

 

September 30,
2025

 

December 31,
2024

Actuarial items and other insurance adjustments

 

$13

 

$(709)

 

$48

Total notable items (1)

 

$13

 

$(709)

 

$48

 

 

 

 

 

 

 

NOTABLE ITEMS BY SEGMENT

 

 

 

 

 

 

Annuities

 

$—

 

$7

 

$48

Life

 

6

 

(11)

 

Run-off

 

7

 

(705)

 

Corporate & Other

 

 

 

Total notable items (1)

 

$13

 

$(709)

 

$48

 

(1) See Non-GAAP and Other Financial Disclosures discussion in this news release.

 

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.27
-4.84 (-2.30%)
AAPL  266.18
+1.60 (0.60%)
AMD  196.60
-3.55 (-1.77%)
BAC  51.07
-1.99 (-3.75%)
GOOG  311.69
-3.21 (-1.02%)
META  637.25
-18.41 (-2.81%)
MSFT  384.47
-12.76 (-3.21%)
NVDA  191.55
+1.73 (0.91%)
ORCL  141.31
-6.77 (-4.57%)
TSLA  399.83
-11.99 (-2.91%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.